Celastrol inhibited the proliferation, migration and clonal expression of the H1299 lung cancer cells and triple-negative breast cancer MDA-MB-231 cells by targeting the YAP-TEAD interactions (Nouri et al., 2019). Here, YAP1 is linked to triple-negative breast carcinoma.